Why Bluebird Bio Shares Are Plunging Today
Bluebird Bio Inc (NASDAQ:BLUE) shares are plummeting after the company signaled a delay in its sickle cell disease drug application…
Related Posts
United Airlines Stock Is Grounded Following Q3 Results: The Details
United Airlines Holdings Inc (NASDAQ: UAL) shares are trading lower in Tuesday's after-hours session on the heels of the company's third-quarter results.
Applied Materials Expects To Investment Up To $4B Over Next Seven Years For R&D Center In Silicon Valley
Applied Materials, Inc. today announced a landmark investment to build the world's largest and most advanced facility for collaborative semiconductor process technology and manufacturing equipment research and
Is Delta 9 Cannabis Inc.’s Q2 2022 Revenue Surge Enough To Offset Net Losses?
Delta 9 Cannabis Inc. (OTC: DLTNF) released its financial results Monday for the three-month period ending June 30, 2022.